Market Tracker

03/03 6:54am ET

NewLink Genetics Corp (NASDAQ:NLNK)

44.43
Delayed Data
As of Mar 02
 +1.35 / +3.13%
Today’s Change
17.32
Today|||52-Week Range
46.40
+11.77%
Year-to-Date

Today’s Trading

Previous close43.08
Today’s open43.04
Day’s range-- - --
Volume794,729
Average volume (3 months)448,961
Market cap$1.2B
Dividend yield--
Data as of 03/02/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-157.77%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratioNM
Price/Sales6.41
Price/Book5.92

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...+0.48+1.22%
USNAUSANA Health Science...+0.99+0.99%
PDLIPDL BioPharma Inc+0.03+0.43%
MACKMerrimack Pharmaceut...+0.57+5.32%
Data as of 03/02/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts